Reconnecting

The current page stays visible while onset.to reconnects in the background.

All weeks

Weekly highlights, Sep 28 – Oct 4, 2026

This week brought an early clinical signal for ayahuasca-assisted grief therapy, a rare kratom safety case, and renewed debate over federal drug policy and oversight.

  1. 1
    Exploratory clinical trial finds ayahuasca combined with meaning reconstruction therapy may ease severe bereavement

    An 84-person exploratory trial found sustained grief and well-being gains with ayahuasca-assisted meaning reconstruction therapy.

    psypost.org Sep 27, 2026 Ayahuasca Clinical
  2. 2
    Kratom-Tee löst bei gesundem 22-Jährigen erstmals in Österreich einen akuten Herzstillstand aus

    A healthy 22-year-old suffered two cardiac arrests after kratom tea, raising concern about severe, potentially overlooked toxicity.

    tirol.orf.at Sep 28, 2026 DE Safety
  3. 3
    MAPS opposes the DEA's attempt to place five lesser-known tryptamines into Schedule I under the Controlled Substances Act

    MAPS is challenging the DEA's renewed bid to place five lesser-known tryptamines in Schedule I, citing research and criminalization costs.

    maps.org Sep 29, 2026 Policy
  4. 4
    Is HHS too cosy with the psychedelic industry, and is the public being misled about psychedelic risks?

    This critique examines alleged HHS-industry ties and asks whether official messaging understates prolonged psychological risks.

    ecstaticintegration.org Oct 2, 2026 LSD Policy